Dr. David Liebeskind has joined our Medical Advisory Board!
March 30, 2023
March 30, 2023
We are excited to announce that Dr. David Liebeskind has joined our medical advisory board!
Dr. Liebeskind is a world-renowned neurologist, Professor of Neurology at the University of California, Los Angeles, neuroimaging specialist, and stroke expert with extensive experience in clinical care.
He is primarily focused on conducting research in the field of stroke by applying advanced neuroimaging methods to gain a better understanding of the condition and enhance its treatment.
His profound knowledge of neurology and stroke will play a vital role in our endeavors to improve the quality of healthcare outcomes for patients.
Our latest
news and publications
news and publications
-
Read
Sentante Receives CE Mark Approval unlocking commercialisation of its Endovascular Robotic platformMay 20, 2026 -
Read
Sentante accepted into FDA Total Product Life Cycle Advisory Program following Breakthrough Device DesignationFebruary 13, 2026 -
Read
Sentante Accelerates Remote Stroke Surgery Innovation With First Live TrialsDecember 12, 2025